Login

Financial Snapshot

Revenue
TTM
$238.3M
Gross Margin
TTM
76.01%
Net Income
TTM
-$170.3M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
175.04%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
190.7M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$27.06M

Stock Price

Loading...
Market Cap: $101.31 Million

About Definitive Healthcare Corp

Definitive Healthcare Corp (NASDAQ: DH) is a healthcare commercial intelligence company that provides data and analytics to organizations selling into or competing within the U.S. healthcare market. Revenue comes almost entirely from subscription fees for access to its SaaS platform, which aggregates and links data from thousands of sources into profiles of healthcare providers, life sciences companies, and related organizations. The company serves approximately 2,330 customers as of December 31, 2025 across three primary end markets: Life Sciences (biopharmaceutical and medical device companies), Provider (hospitals, health systems, and care delivery organizations), and Diversified (healthcare IT companies, staffing firms, commercial real estate firms, financial institutions, and marketing agencies). Founded in 2011 and incorporated as Definitive Healthcare Corp. in May 2021, the company completed its IPO of Class A common stock on September 17, 2021. The platform is U.S.-focused, covering what the company describes as the entire U.S. healthcare ecosystem. The company's stated defensive moat is its proprietary data platform, built through first-party research and aggregation of billions of data points.

Revenue model
Subscription fees for SaaS-based access to healthcare commercial intelligence data; the company generates substantially all revenue from subscriptions, as disclosed in the FY2025 10-K filed 2026-02-26.
Products and services
SaaS platform providing healthcare commercial intelligence data, including modules covering sales, marketing, clinical research, product development, strategy, talent acquisition, and physician network management.
Customers and end markets
Approximately 2,330 customers as of December 31, 2025. End markets: Life Sciences (biopharmaceutical, medical device), Provider (hospitals, health systems, care delivery organizations), and Diversified (healthcare IT, staffing, commercial real estate, financial institutions, marketing and advertising agencies). Functional buyers within customer organizations include sales, marketing, clinical research, product development, strategy, and talent acquisition teams.
Value-chain role
Data aggregator and analytics platform provider; sits upstream of commercial go-to-market functions for companies selling into the U.S. healthcare market.
Geographic exposure
U.S. healthcare market focus, as described in the FY2025 10-K filed 2026-02-26. No international segment disclosed in the excerpts.

Source: SEC 10-K, filed 2026-02-26

Industry: Services-Prepackaged Software Peers: Veradigm Inc. Claritev Corp Certara Inc Doximity Inc Evolent Health Inc GoodRx Holdings Inc Teladoc Health Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support